Clinical Trials Browser

Phase 1 × durvalumab × Endocrine × Clear all

NCT03122496 2022-06-08

Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

Phase 1 Completed

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic